U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07284498) titled 'Treatment of Seizures in Neonate With HIE' on Nov. 16.
Brief Summary: Aim of the study To evaluate and compare phenobarbital's and levetiracetam's safety and efficacy for treating seizures in neonates with moderate to severe HIE
Study Start Date: Jan. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Neonatal Seizures
HIE - Hypoxic - Ischemic Encephalopathy
Intervention:
DRUG: Phenobarbital
Phenobarbital is strongly recommended by the World Health Organization as the first-line treatment of neonatal seizures and is the standard of care at most institutions
DRUG: Levetiracetam
levetiracetam has emerged as an alternative Anti-se...